Show simple item record

dc.contributor.authorOnikanni, Sunday Amos
dc.contributor.authorLawal, Bashir
dc.contributor.authorFadaka, Adewale Oluwaseun
dc.contributor.authorBakare, Oluwafemi
dc.date.accessioned2023-03-16T07:37:21Z
dc.date.available2023-03-16T07:37:21Z
dc.date.issued2023
dc.identifier.citationOnikanni, S.A.; Lawal, B.; Fadaka, A.O.; Bakare, O.; Adewole, E.; Taher, M.; Khotib, J.; Susanti, D.; Oyinloye, B.E.; Ajiboye, B.O.; et al. Computational and Preclinical Prediction of the Antimicrobial Properties of an Agent Isolated from Monodora myristica: A Novel DNA Gyrase Inhibitor. Molecules 2023, 28, 1593. https://doi.org/10.3390/ molecules28041593en_US
dc.identifier.urihttps://doi.org/10.3390/ molecules28041593
dc.identifier.urihttp://hdl.handle.net/10566/8594
dc.description.abstractThe African nutmeg (Monodora myristica) is a medically useful plant. We, herein, aimed to critically examine whether bioactive compounds identified in the extracted oil of Monodora myristica could act as antimicrobial agents. To this end, we employed the Schrödinger platform as the computational tool to screen bioactive compounds identified in the oil of Monodora myristica. Our lead compound displayed the highest potency when compared with levofloxacin based on its binding affinity. The hit molecule was further subjected to an Absorption, Distribution, Metabolism, Excretion (ADME) prediction, and a Molecular Dynamics (MD) simulation was carried out on molecules with PubChem IDs 529885 and 175002 and on three standards (levofloxacin, cephalexin, and novobiocin). The MD analysis results demonstrated that two molecules are highly compact when compared to the native protein; thereby, this suggests that they could affect the protein on a structural and a functional level. The employed computational approach demonstrates that conformational changes occur in DNA gyrase after the binding of inhibitors; thereby, this resulted in structural and functional changes. These findings expand our knowledge on the inhibition of bacterial DNA gyrase and could pave the way for the discovery of new drugs for the treatment of multi-resistant bacterial infections.en_US
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.subjectAntibioticsen_US
dc.subjectConformationalen_US
dc.subjectLevofloxacinen_US
dc.subjectMonodora myristicaen_US
dc.subjectSchrödingeren_US
dc.titleComputational and preclinical prediction of the antimicrobial properties of an agent isolated from monodora myristica: A novel dna gyrase inhibitoren_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record